4.8 Review

TGFβ in cancer

期刊

CELL
卷 134, 期 2, 页码 215-230

出版社

CELL PRESS
DOI: 10.1016/j.cell.2008.07.001

关键词

-

资金

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NCI NIH HHS [R37 CA034610, P30 CA008748] Funding Source: Medline

向作者/读者索取更多资源

The transforming growth factor beta (TGF beta) signaling pathway is a key player in metazoan biology, and its misregulation can result in tumor development. The regulatory cytokine TGF beta exerts tumor-suppressive effects that cancer cells must elude for malignant evolution. Yet, paradoxically, TGF beta also modulates processes such as cell invasion, immune regulation, and microenvironment modification that cancer cells may exploit to their advantage. Consequently, the output of a TGF beta response is highly contextual throughout development, across different tissues, and also in cancer. The mechanistic basis and clinical relevance of TGF beta's role in cancer is becoming increasingly clear, paving the way for a better understanding of the complexity and therapeutic potential of this pathway.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据